- Walgreens puts its money where its mouth is with World AIDS Day campaign
- UnitedHealth: Cost of diabetes could be $3.35 trillion by 2020
- With health reform outlook dimmed, pharmacy can’t abandon its agenda
- Bartell to cease filling Medicaid prescriptions at 15 locations
- With new push, pharmacy groups seek inclusion in health reform’s ACOs
NEW YORK Elizabeth Arden has signed an exclusive global licensing deal with music star Taylor Swift to develop her own line of fragrance products.
The deal includes the development, marketing and distribution of fragrances and ancillary products. The first fragrance will debut in prestige retailers in North America during fall 2011. Swift will be involved in all aspects of product development, packaging and advertising.
"We are very enthusiastic about partnering with Taylor Swift,"stated Ronald Rolleston, EVP of Elizabeth Arden. "Her rise to superstardom has been meteoric, and her multiple awards and incredible record sales are a testament to her extraordinary talent. Equally important to us is what Taylor represents as an artist: a role model who inspires her global fan base every day. We look forward to launching a new fragrance brand that reflects every facet of this extremely talented young artist."